Related references
Note: Only part of the references are listed.Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34- fraction
David C. Taussig et al.
BLOOD (2010)
Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
Florence C. Guibal et al.
BLOOD (2009)
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features
Claudia Haferlach et al.
BLOOD (2009)
Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells
Liqing Jin et al.
CELL STEM CELL (2009)
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives
Brunangelo Falini et al.
CURRENT OPINION IN ONCOLOGY (2009)
A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF
N. Bolli et al.
LEUKEMIA (2009)
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications
B. Falini et al.
LEUKEMIA (2009)
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia
Brunangelo Falini et al.
HAEMATOLOGICA (2008)
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia
M. P. Martelli et al.
LEUKEMIA (2008)
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
Timothy J. Ley et al.
NATURE (2008)
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
Richard F. Schlenk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin
Ramiro Garzon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc plus AML
M. P. Martelli et al.
LEUKEMIA (2008)
Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region
Fumihiko Ishikawa et al.
NATURE BIOTECHNOLOGY (2007)
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants
Niccolo Bolli et al.
CANCER RESEARCH (2007)
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML):: biologic and clinical features
Brunangelo Falini et al.
BLOOD (2007)
Expression of the target receptor CD33 in CD34(+)/CD38(-)/CD123(+) AML stem cells
A. W. Hauswirth et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: impact on WHO classification
Laura Pasqualucci et al.
BLOOD (2006)
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia
Brunangelo Falini et al.
BLOOD (2006)
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9
Andrei V. Krivtsov et al.
NATURE (2006)
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML
Brunangelo Falini et al.
BLOOD (2006)
A new Logicle display method avoids deceptive effects of logarithmic scaling for low signals and compensated data
David R. Parks et al.
CYTOMETRY PART A (2006)
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
Christian Thiede et al.
BLOOD (2006)
AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML
DJ Pearce et al.
BLOOD (2006)
Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia
DC Taussig et al.
BLOOD (2005)
Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML):: association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance
RGW Verhaak et al.
BLOOD (2005)
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin
H Quentmeier et al.
LEUKEMIA (2005)
Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance
M Alcalay et al.
BLOOD (2005)
Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples
DJ Pearce et al.
STEM CELLS (2005)
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
B Falini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Concepts of human leukemic development
JK Warner et al.
ONCOGENE (2004)
NOD/SCID/γcnull mouse:: an excellent recipient mouse model for engraftment of human cells
M Ito et al.
BLOOD (2002)
High frequency of immunophenotype changes in acute myeloid leukemia at relapse:: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)
MR Baer et al.
BLOOD (2001)